Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Recipharm AB (publ)
  6. Summary
    RECI B   SE0005757267

RECIPHARM AB (PUBL)

(RECI B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Estimated financial data (e)
Sales 2019 7 461 M 865 M 865 M
Net income 2019 343 M 39,8 M 39,8 M
Net Debt 2019 4 152 M 481 M 481 M
P/E ratio 2019 29,4x
Yield 2019 -
Sales 2020 11 124 M 1 289 M 1 289 M
Net income 2020 339 M 39,3 M 39,3 M
Net Debt 2020 8 932 M 1 035 M 1 035 M
P/E ratio 2020 55,3x
Yield 2020 -
Capitalization 23 481 M 2 766 M 2 722 M
EV / Sales 2019 1,90x
EV / Sales 2020 2,79x
Nbr of Employees -
Free-Float 56,3%
More Financials
Company
Recipharm AB (publ) is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). The Company's acivities are devided into four business segments: Advanced Delivery Systems, which develops and manufactures inhalation products and devices including integrated drug solutions, medical check valves and injection devices. Steriles, which manufactures sterile... 
Sector
Pharmaceuticals
Calendar
09/30Presentation
More about the company
Ratings of Recipharm AB (publ)
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about RECIPHARM AB (PUBL)
08/24RECIPHARM : launches new laboratory to expand analytical services offering
AQ
08/24Recipharm AB Appoints Mr. Manivel Thangapragasam as Associate Director
CI
08/24Recipharm Launches New Laboratory to Expand Analytical Services Offering
CI
08/09TOLERANZIA AB (PUBL) : The board of directors proposes extraordinary general meeting to re..
AQ
07/15RECIPHARM : invests in fill finish capacity
AQ
07/15Recipharm Invests in Fill Finish Capacity
CI
07/06RECIPHARM : Enters Deal to Operate Fill-Finish Factory in Morocco
MT
07/06RECIPHARM : signs Memorandum of Understanding (MOU) for the fill finish of vaccines and bi..
AQ
07/06Recipharm Signs Memorandum of Understanding for the Fill Finish of Vaccines and Biother..
CI
07/01Moderna, Inc. and Recipharm Site in France Manufacturing Covid-19 Vaccine Moderna Follo..
CI
04/13NANOLOGICA : Nomination Committee Proposes Thomas Eldered as New Board Member of Nanologic..
AQ
04/09RECIPHARM : Notice to attend the annual general meeting of Recipharm AB (publ)
AQ
04/08RECIPHARM AB(OM : RECI B) dropped from OMX Nordic All-Share Index
CI
03/02RECIPHARM : names 2020 International Environmental Award winner
AQ
03/01EQT : Roar BidCo announces final outcome in the offer to the shareholders in Recipharm AB ..
AQ
More news
News in other languages on RECIPHARM AB (PUBL)
02/08Eurazeo prépare une vente du groupe pharmaceutique Seqens, selon des sources
01/28EN DIRECT DES MARCHES : STMicroelectronics, Elior, TechnipFMC, Valneva, Apple, Tesla, BMW,..
01/11La bourse reste hermétique au déclin de Trump
01/11AVIS D'ANALYSTES DU JOUR : Air Liquide, Airbus, Aperam, Fresenius, LafargeHolcim, Saint-Go..
2020Pas de Brexit, pas de plan US, mais des vaccins
More news
Chart RECIPHARM AB (PUBL)
Duration : Period :
Recipharm AB (publ) Technical Analysis Chart | RECI B | SE0005757267 | MarketScreener
Income Statement Evolution
Managers and Directors
Marc Funk Chief Executive Officer
Daniela Sylvia Beate Roxin Chief Financial Officer
Richard Ridinger Chairman
Ulrike Lemke Chief Technology Officer
Thomas Bengt Eldered Director
Sector and Competitors